NHS overcrowding leads to ambulances being turned away
December 17, 2018Sales and Marketing Hopsitals, NHS, UK, health, politics
NHS England’s first weekly report of the winter has revealed that 95% of hospital beds are occupied, while anything above …
Novartis withdraw marketing application for heart drug
December 17, 2018Sales and Marketing CHMP, EMA, MI, Novartis, pharma
Swiss multinational Novartis has withdrawn a European Medicines Agency (EMA) marketing application for canakinumab for the prevention of serious events …
CHMP approve Bristol-Myers Squibb’s Sprycel for paediatric patients with Ph+ ALL
December 17, 2018Sales and Marketing BMS, Bristol-Myers Squibb, Cancer, Sprycel, all
New Jersey-based firm Bristol -Myers Squibb today announced that the Committee for Medicinal Products for Human Use (CHMP) of the …
No-deal Brexit stockpiling puts pressure on supply chain
December 17, 2018Sales and Marketing brexit, no-deal, pharma, pricing, supply chain
The stockpiling of medicines in preparation for a no-deal Brexit is putting pressure on the supply chain and causing shortages …
J&J shares plummet after asbestos cover up allegations emerge
December 17, 2018Sales and Marketing J&J, JJ, Johnson & Johnson, asbestos, reuters
Shares in American healthcare firm Johnson & Johnson plummeted on Friday after news agency Reuters reported that the New Jersey-based …
Top Ten most popular articles on Pharmafile.com this week!
December 14, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Akorn, Boehringer, Novartis, Pfizer, Trump, UK, pharmafile, top 10
Business seemed to be the theme this week as Akorn’s acquisition of Fresenius fell through, while Boehringer announced a restructuring …
‘Significant’ health outcomes gap still exists in Scotland
December 14, 2018Medical Communications NHS, Scotland, UK, health, inequality
There is a significant gap in health outcomes between the most and least deprived areas of Scotland, a Scottish government …
Data reveals November’s performance was worst on record for NHS
December 14, 2018Medical Communications NHS, NHS England, UK, funding, investment, wait times
November saw the worst A&E performance on record, according to data released by NHS England. The number of patients who …
York-based biotech expands premises after $2.2 million investment
December 14, 2018Medical Communications UK, aptamer, biotech, funding, investment, york science park
The York-based Aptamer Group is set to expand its premises after securing $2.2 million in overseas investment in June of …
Bausch Health buy bankrupt Synergy Pharmaceuticals for $200m
December 13, 2018Business Services GI, IBS, basuch, cnstipation, synergy pharma
Bankrupt drug developer Synergy Pharmaceuticals has announced that the company is to be acquired by Canadian speciality pharma firm Bausch …
MSD announced collaboration with Brazilian non-profit over development of dengue vaccine
December 13, 2018Business Services, Medical Communications, Research and Development Dengue fever, HPV, hepatitis a, vaccines, virus
US firm Merck & Co have announced a collaboration with the Brazilian non-profit Instituto Butantan, with the intention of developing …
Those living in rural areas less likely to survive cancer, study shows
December 13, 2018Medical Communications, Research and Development Cancer, health, oncology, rural, survival, urban
Those living in rural areas are less likely to survive cancer than their city dwelling counterparts, according to new research …
Government choose England top pharmacist to address overprescribing and polypharmacy
December 13, 2018Medical Communications, Research and Development England, Matt Hancock, NHS, medicine, pharma
England’s chief pharmaceutical officer Dr Keith Ridge has been chosen to look into ‘problematic’ overprescribing in the NHS. The move …
NICE reject two treatments for fatal, ultra-rare disease – hATTR
December 13, 2018Medical Communications, Research and Development, Sales and Marketing
The NHS’ cost effectiveness body NICE has rejected two treatments for the rare inherited condition, hereditary transthyretin-related amyliodsis (hATTR), over …
The December issue of Pharmafocus is available to read online now!
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eisai, GSK, Gilead, Mundipharma, Pharmafocus, mesothelioma, pharma
The December edition of Pharmafocus is live and available to read online now!Brexit continues to dominate the headlines inside and …
FDA rejects Mallinckrodt’s abuse-deterrent version of opioid painkiller Roxicodone
December 12, 2018Research and Development, Sales and Marketing FDA, Mallinckrodt, Roxicodone, opioid crisis, opioids, pharma
Mallinckrodt has hit a snag in its quest to bring an abuse-deterrent version of Roxicodone (oxycodone hydrochloride) to market in …
Allergan strengthens Finance Leadership Team with two appointments
December 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Allergan, MIT, Regeneron, appointment, pharma
The Dublin-headquartered multinational Allergan has appointed two experienced pharma investors to its Finance Leadership Team. The biopharmaceutical firm yesterday announced …
Scottish Medicines Consortium approves Verkazia for severe eye condition in children and adolescents
December 12, 2018Research and Development, Sales and Marketing SMC, Santen, Scotland, UK, Verkazia, pharma, vernal keratoconjunctivitis
UK-based pharmaceutical firm Santen has announced that the Scottish Medicines Consortium has awarded approval to its eye drops emulsion Verkazia …
Amgen donate $2m towards increasing diversity in clinical trials
December 12, 2018Research and Development Amgen, USA, clinical trials, diversity, donation
American multinational Amgen has teamed up with the Lazarex Cancer Foundation in support of an initiative aimed at increasing access …
Atopic dermatitis market set to almost triple in value over next 10 years
December 12, 2018Research and Development atopic dermatitis, eczema, global data, markets, money
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData. The market …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
